We then examined the PD1 expression levels in 20 DLBCL patients from the HBsAg+ group and 31 DLBCL patients from the HBsAg—group and investigated the association between PD1 expression and the clinical prognosis of patients in this cohort. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.